CVE-2022-41414 Liferay Portal Insecure Default Configuration in auth.login.prompt.enabled
Attackers can enumerate usernames, site names, and pages due to an insecure default configuration in Liferay Portal.
- Exploited in the wild
- Not known
- Login needed
- Not needed
- Attackable
- Over the internet
- Victim action needed
- Not needed
- Fix
- Available
What is CVE-2022-41414?
CVE-2022-41414 is a medium-severity vulnerability in Liferay Liferay Portal, published on 7 Oct 2022. An attacker can exploit it over the internet without logging in, with no action from the victim.
Official description
An insecure default in the component auth.login.prompt.enabled of Liferay Portal v7.0.0 through v7.4.2 allows attackers to enumerate usernames, site names, and pages.
Weakness: CWE-276
Which versions are affected by CVE-2022-41414?
4 open source packages ship an affected version, including com.liferay.portal:com.liferay.portal.impl and com.liferay.portal:release.portal.bom. It affects 1 product.
| Package | Affected | Fixed in |
|---|---|---|
com.liferay.portal:com.liferay.portal.impl Maven | All versions | 8.0.0 |
com.liferay.portal:com.liferay.portal.impl Maven | All versions | 8.0.0 |
com.liferay.portal:release.portal.bom Maven | From 7.0.0-a1 | 7.4.2-ga3 |
com.liferay.portal:release.portal.bom Maven | From 7.0.0-a1 | 7.4.2-ga3 |
Products include Liferay Liferay Portal.
How do I fix CVE-2022-41414?
Upgrade com.liferay.portal:com.liferay.portal.impl to 8.0.0 or later.
Is CVE-2022-41414 being exploited?
There is no known exploitation of CVE-2022-41414 in the wild and no public exploit code.
Other vulnerabilities in Liferay Liferay Portal
- CVE-2020-7961 Liferay Portal Deserialization of Untrusted Data
- CVE-2021-33990 File upload in n/a
- CVE-2019-16891 Liferay Portal Allows RCE via Deserialization of a JSON Payload
- CVE-2023-47797 Liferay Portal XSS with `p_l_back_url_title` on edit content page
- CVE-2020-13445 Liferay Portal and Liferay DXP Vulnerable to Arbitrary Code Execution
Sources
Also known as GHSA-9427-7f65-88c8.